Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine 5 mg in adults with major depressive disorder
NCT00672958Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of vortioxetine in major depressive disorder (MDD), sponsored by Takeda. Started Apr 2008; status: completed.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00672958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672958.